Lamictal and Chronic thyroiditis - a phase IV clinical study of FDA data

Summary:

Chronic thyroiditis is reported as a side effect among people who take Lamictal (lamotrigine), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Chronic thyroiditis when taking Lamictal. It is created by eHealthMe based on reports of 74,218 people who have side effects when taking Lamictal from the FDA, and is updated regularly.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 82,626 Lamictal users. Check the latest studies of Lamictal.

What is Chronic thyroiditis?

Chronic thyroiditis (long lasting inflammation of thyroid gland) is found to be associated with 457 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Chronic thyroiditis.

On Jul, 21, 2026

74,218 people reported to have side effects when taking Lamictal.
Among them, 38 people (0.05%) have Chronic thyroiditis.

Could Lamictal cause Chronic thyroiditis?

Among these 38 people:

How long have people been on Lamictal when they have Chronic thyroiditis? *

What is the gender of people who have Chronic thyroiditis when taking Lamictal? *

female: 67.65 %
male: 32.35 %

What is the age of people who have Chronic thyroiditis when taking Lamictal? *

What are other drugs people take besides Lamictal? *

What are other side effects people have besides Chronic thyroiditis? *

Fatigue (feeling of tiredness): 13 people, 34.21%
Rashes (redness): 11 people, 28.95%
Peripheral Swelling: 9 people, 23.68%
Nausea And Vomiting: 9 people, 23.68%
Weight Decreased: 9 people, 23.68%
Burning Sensation: 8 people, 21.05%
Upper Respiratory Tract Infection: 8 people, 21.05%
The Flu (the flu is caused by an influenza virus): 7 people, 18.42%
High Blood Pressure: 7 people, 18.42%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 18.42%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 5 people, 13.16%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 4 people, 10.53%
Ovarian Cancer Stage Iii: 4 people, 10.53%
Ovarian Cancer (cancer of ovary): 4 people, 10.53%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.89%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 7.89%
Urinary Tract Infection: 2 people, 5.26%
Birth Control: 2 people, 5.26%
Type 2 Diabetes: 1 person, 2.63%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Lamictal and have Chronic thyroiditis?

- Check whether Chronic thyroiditis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamictal:

Lamictal (82,626 reports)

Browse all side effects of Lamictal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic thyroiditis:

Chronic thyroiditis (457 drugs)

Browse all the conditions that are associated with Chronic thyroiditis:

Chronic thyroiditis (1,084 conditions)

Related publications that referenced our studies

Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamictal) and Lamictal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.